Role of transarterial chemoembolization in relation with sorafenib for patients with advanced hepatocellular carcinoma

BACKGROUND: Although sorafenib is considered standard therapy for advanced hepatocellular carcinoma (HCC), actual treatments vary. We evaluated the effects of different treatment strategies on overall survival. METHODS: A retrospective study of sorafenib-treated patients with advanced HCC was conduc...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncotarget
Main Authors: Ha, Yeonjung, Lee, Danbi, Shim, Ju Hyun, Lim, Young-Suk, Lee, Han Chu, Chung, Young-Hwa, Lee, Yung Sang, Park, Sook Ryun, Ryu, Min-Hee, Ryoo, Baek-Yeol, Kang, Yoon-Koo, Kim, Kang Mo
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2016
Teme:
Clinical Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5342054/
https://ncbi.nlm.nih.gov/pubmed/27494871
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11030
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki